Global Pain Management Drugs Market 2018-2022

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: PIPELINE ANALYSIS

• Pain management pipeline

PART 06: MARKET SIZING

• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 08: MARKET SEGMENTATION BY PAIN TYPES

• Segmentation by pain types
• Nociceptive pain
• Neuropathic pain
• Psychogenic pain

PART 09: MARKET SEGMENTATION BY PRODUCT

• Segmentation by product
• Comparison by product
• Opioids – Market size and forecast 2017-2022
• NSAIDs – Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by product

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 14: MARKET TRENDS

• Increase in prevalence of pain associated with chronic diseases
• Significant increase in the use of opioids for pain management
• Novel drug delivery systems and novel targets for pain management

PART 15: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 16: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Endo Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson
• Pfizer

PART 17: APPENDIX

• List of abbreviations

PART 18: EXPLORE TECHNAVIO